NOAH website
Compendium home page
Statement of active substances
Marketing authorisation holder and Manufacturer
Target species, dosage for each species, method and route of administration, advice on correct administration
Indications, contra-indications, undesirable effects
Withdrawal Period
Special storage conditions
Special warning(s)
Special precautions for the disposal of unused medicinal product or waste material, if any
Date on which the package insert was last revised
Other information
Marketing authorisation number
 
You are here: Introduction > Marketing authorisation number
 
        PreviousNo next
 
Fevaxyn Pentofel:  Marketing authorisation number
 
 
Fevaxyn Pentofel
Marketing authorisation number
EU/2/96/002/001.
           
 
        PreviousNo next
  Date updated: 10 October 2006